Cargando…
A novel diagnostic model for insulinoma
The aim is to describe a simple and feasible model for the diagnosis of insulinoma. This retrospective study enrolled 37 patients with insulinoma and 44 patients with hypoglycemia not due to insulinoma at the First Affiliated Hospital of Guangxi Medical University. General demographic and clinical c...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9346017/ https://www.ncbi.nlm.nih.gov/pubmed/35916979 http://dx.doi.org/10.1007/s12672-022-00534-w |
_version_ | 1784761554883837952 |
---|---|
author | Wang, Feng Yang, Zhe Chen, XiuBing Peng, Yiling Jiang, HaiXing Qin, ShanYu |
author_facet | Wang, Feng Yang, Zhe Chen, XiuBing Peng, Yiling Jiang, HaiXing Qin, ShanYu |
author_sort | Wang, Feng |
collection | PubMed |
description | The aim is to describe a simple and feasible model for the diagnosis of insulinoma. This retrospective study enrolled 37 patients with insulinoma and 44 patients with hypoglycemia not due to insulinoma at the First Affiliated Hospital of Guangxi Medical University. General demographic and clinical characteristics; hemoglobin A1c (HbA1c), insulin and C-peptide concentrations; and the results of 2-h oral glucose tolerance tests (OGTT) were recorded, and a logistic regression model predictive of insulinoma was determined. Body mass index (BMI), HbA1c concentration, 0-h C-peptide concentration, and 0-h and 1-h plasma glucose concentrations (P < 0.05 each) were independently associated with insulinoma. A regression prediction model was established through multivariate logistics regression analysis: Logit p = 7.399+(0.310 × BMI) − (1.851 × HbA1c) − (1.467 × 0-h plasma glucose) + (1.963 × 0-h C-peptide) − (0.612 × 1-h plasma glucose). Using this index to draw a receiver operating characteristic (ROC) curve, the area under the curve (AUC) was found to be 0.957. The optimal cut-off value was − 0.17, which had a sensitivity of 89.2% and a specificity of 86.4%. Logit P ≥ − 0.17 can be used as a diagnostic marker for predicting insulinoma in patients with hypoglycemia. |
format | Online Article Text |
id | pubmed-9346017 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Springer US |
record_format | MEDLINE/PubMed |
spelling | pubmed-93460172022-08-04 A novel diagnostic model for insulinoma Wang, Feng Yang, Zhe Chen, XiuBing Peng, Yiling Jiang, HaiXing Qin, ShanYu Discov Oncol Research The aim is to describe a simple and feasible model for the diagnosis of insulinoma. This retrospective study enrolled 37 patients with insulinoma and 44 patients with hypoglycemia not due to insulinoma at the First Affiliated Hospital of Guangxi Medical University. General demographic and clinical characteristics; hemoglobin A1c (HbA1c), insulin and C-peptide concentrations; and the results of 2-h oral glucose tolerance tests (OGTT) were recorded, and a logistic regression model predictive of insulinoma was determined. Body mass index (BMI), HbA1c concentration, 0-h C-peptide concentration, and 0-h and 1-h plasma glucose concentrations (P < 0.05 each) were independently associated with insulinoma. A regression prediction model was established through multivariate logistics regression analysis: Logit p = 7.399+(0.310 × BMI) − (1.851 × HbA1c) − (1.467 × 0-h plasma glucose) + (1.963 × 0-h C-peptide) − (0.612 × 1-h plasma glucose). Using this index to draw a receiver operating characteristic (ROC) curve, the area under the curve (AUC) was found to be 0.957. The optimal cut-off value was − 0.17, which had a sensitivity of 89.2% and a specificity of 86.4%. Logit P ≥ − 0.17 can be used as a diagnostic marker for predicting insulinoma in patients with hypoglycemia. Springer US 2022-08-02 /pmc/articles/PMC9346017/ /pubmed/35916979 http://dx.doi.org/10.1007/s12672-022-00534-w Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Research Wang, Feng Yang, Zhe Chen, XiuBing Peng, Yiling Jiang, HaiXing Qin, ShanYu A novel diagnostic model for insulinoma |
title | A novel diagnostic model for insulinoma |
title_full | A novel diagnostic model for insulinoma |
title_fullStr | A novel diagnostic model for insulinoma |
title_full_unstemmed | A novel diagnostic model for insulinoma |
title_short | A novel diagnostic model for insulinoma |
title_sort | novel diagnostic model for insulinoma |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9346017/ https://www.ncbi.nlm.nih.gov/pubmed/35916979 http://dx.doi.org/10.1007/s12672-022-00534-w |
work_keys_str_mv | AT wangfeng anoveldiagnosticmodelforinsulinoma AT yangzhe anoveldiagnosticmodelforinsulinoma AT chenxiubing anoveldiagnosticmodelforinsulinoma AT pengyiling anoveldiagnosticmodelforinsulinoma AT jianghaixing anoveldiagnosticmodelforinsulinoma AT qinshanyu anoveldiagnosticmodelforinsulinoma AT wangfeng noveldiagnosticmodelforinsulinoma AT yangzhe noveldiagnosticmodelforinsulinoma AT chenxiubing noveldiagnosticmodelforinsulinoma AT pengyiling noveldiagnosticmodelforinsulinoma AT jianghaixing noveldiagnosticmodelforinsulinoma AT qinshanyu noveldiagnosticmodelforinsulinoma |